scholarly journals Clinical characteristics and outcomes in hospitalized adult influenza patients: an observational study from Norway 2014–2018

2022 ◽  
pp. 1-11
Author(s):  
Torgun Wæhre ◽  
Gro Tunheim ◽  
Johanna Eva Bodin ◽  
Ida Laake ◽  
Dag Kvale ◽  
...  
Keyword(s):  
Observational Study ◽  
Clinical Characteristics

scholarly journals Clinical characteristics of hypertrophic herpes simplex genitalis and treatment outcomes of imiquimod: a retrospective observational study

2015 ◽  
Vol 33 ◽  
pp. 165-170 ◽  
Author(s):  
Charussri Leeyaphan ◽  
Theetat M. Surawan ◽  
Pornchai Chirachanakul ◽  
Nuntida Prasertworonun ◽  
Praewphan Punyaratabandhu ◽  
...  
Keyword(s):  
Herpes Simplex ◽  
Observational Study ◽  
Treatment Outcomes ◽  
Clinical Characteristics ◽  
Retrospective Observational Study

Patients with HFpEF and HFmrEF have different clinical characteristics in Turkey: A multicenter observational study

2019 ◽  
Vol 61 ◽  
pp. 88-95 ◽  
Author(s):  
Bülent Özlek ◽  
Eda Özlek ◽  
Hicaz Zencirkıran Ağuş ◽  
Mehmet Tekinalp ◽  
Serkan Kahraman ◽  
...  
Keyword(s):  
Observational Study ◽  
Clinical Characteristics ◽  
Multicenter Observational Study

scholarly journals Comparison of the clinical characteristics and outcomes of hospitalized adult COVID-19 and influenza patients – a prospective observational study

2020 ◽  
pp. 1-11
Author(s):  
Raija Auvinen ◽  
Hanna Nohynek ◽  
Ritva Syrjänen ◽  
Jukka Ollgren ◽  
Tuija Kerttula ◽  
...  
Keyword(s):  
Observational Study ◽  
Clinical Characteristics ◽  
Prospective Observational Study

scholarly journals Clinical characteristics of HIV-1-infected patients with high levels of plasma interferon-γ: a multicenter observational study

2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Dai Watanabe ◽  
Tomoko Uehira ◽  
Sachiko Suzuki ◽  
Erina Matsumoto ◽  
Takashi Ueji ◽  
...  
Keyword(s):  
Observational Study ◽  
Clinical Characteristics ◽  
Interferon Γ ◽  
Multicenter Observational Study ◽  
Hiv 1

scholarly journals Middle East experience from the Asia And Latin America Fracture Observational Study (ALAFOS): Baseline characteristics of postmenopausal women with osteoporosis using teriparatide

2020 ◽  
Vol 48 (8) ◽  
pp. 030006052094085
Author(s):  
Abdul Aziz Elsalmawy ◽  
Nadia S. Al-Ali ◽  
Yasser Yaghi ◽  
Hussein Assaggaf ◽  
Ghassan Maalouf ◽  
...  
Keyword(s):  
Latin America ◽  
Middle East ◽  
Observational Study ◽  
United Arab Emirates ◽  
Clinical Characteristics ◽  
Rating Scale ◽  
Osteoporotic Fractures ◽  
Visual Analog Scale Score ◽  
Numeric Rating Scale ◽  
Mineral Density

Objective We aimed to describe the baseline clinical characteristics and fracture history of patients taking teriparatide in routine clinical practice in the Middle East (ME) subregional cohort of the Asia and Latin America Fracture Observational Study (ALAFOS). Methods Herein, we report baseline clinical characteristics of patients who were prescribed teriparatide (20 µg/day, subcutaneous injection) in four participant ME countries (Saudi Arabia, United Arab Emirates, Kuwait, and Lebanon). Results The ME cohort included 707 patients mean (SD) age 69.3 (11.6) years. Mean (SD) bone mineral density (BMD) T-scores at baseline were −3.13 (1.28) for lumbar spine, −2.88 (0.94) for total hip, and −2.65 (1.02) for femoral neck. Osteoporotic fractures after age 40 years were reported in 45.8% (vertebral fracture 14.4%, hip fracture 18.4%) and comorbidities in 57.4% of patients. Before starting teriparatide, 19.9% of patients took other osteoporosis medications. The median (Q1; Q3) EuroQoL 5-Dimension 5-Level visual analog scale score for perceived overall health status was 70 (50; 80). Mean (SD) worst back pain in the previous 24 hours was 4.0 (3.2) using a 10-point numeric rating scale. Conclusion This analysis indicated that in ME countries, teriparatide is usually prescribed to patients with low BMD and high comorbidities, with prior fractures.

scholarly journals The Controversy Continues Again: which Direct Anticoagulant is More Effective and Safe when Administered to Patients with Atrial Fibrillation?

2020 ◽  
Vol 16 (4) ◽  
pp. 635-637
Author(s):  
S. Yu. Martsevich
Keyword(s):  
Atrial Fibrillation ◽  
Ischemic Stroke ◽  
Observational Study ◽  
Statistical Methods ◽  
Clinical Characteristics ◽  
Large Database ◽  
Systemic Embolism ◽  
Made In

The data from the observational study of M. Fralick et al. were analyzed in the article. The authors analyzed a large database of patients with atrial fibrillation and concluded that rivaroxaban is inferior to apixaban in its ability to prevent ischemic stroke and systemic embolism and is more likely to cause bleeding. Serious methodological defects of the analysis take place. No statistical methods are capable of correcting the absence of such important information in the database as the doctor's motives for prescribing a particular drug, as well as the patient's adherence to taking it. It is also noted that the patients included in the study, according to clinical characteristics, did not correspond to the typical population of patients with atrial fibrillation. The author considers the conclusions made in the mentioned work to be unauthorized.

Sign in / Sign up

Export Citation Format

Share Document